Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lord

Showing results (471-480 of 1,033) with videos related to

Pageof 104
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 4, 1998
IL-3-mediated enhancement of particulate antigen presentation by macrophagesE M Lord, K Y Yeh, J A Moran, et al.
Leukemia Research|January 1, 1990
Phorbol myristate acetate treatment of normal human myeloid blast cells promotes monopoiesis and inhibits granulopoiesisC M Bunce, W N Patton, J D Pound, et al.
Journal of Leukocyte Biology|August 1, 2002
Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokinesGraham M Lord, Giuseppe Matarese, Jane K Howard, et al.
Alimentary Pharmacology & Therapeutics|September 11, 2019
Review article: impact of exercise on physical frailty in patients with chronic liver diseaseFelicity R Williams, Annalisa Berzigotti, Janet M Lord, et al.
Cancer Research|January 15, 1996
2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumorsS M Evans, W T Jenkins, B Joiner, et al.
Haematology and Blood Transfusion|January 1, 1987
Lineage determination during haemopoiesisG Brown, C M Bunce, J M Lord, et al.
The American Journal of Pathology|January 27, 2004
Leptin-deficient mice are protected from accelerated nephrotoxic nephritisRuth M Tarzi, H Terence Cook, Ian Jackson, et al.
Gut|January 26, 2020
Regulatory T-cell therapy in Crohn's disease: challenges and advancesJennie N Clough, Omer S Omer, Scott Tasker, et al.
Hematology (Amsterdam, Netherlands)|June 15, 2007
Circulating T cells in patients with untreated acute myelogenous leukemia are heterogeneous and can be activated through the CD3/TCR complexElisabeth Ersvaer, Peter Hampson, Øystein Wendelbo, et al.
Psychiatric Services (Washington, D.C.)|July 27, 2022
Peer Support Specialist Work and Experiences During the COVID-19 Pandemic: A National Longitudinal StudyWallis E Adams, E Sally Rogers, Emily M Lord, et al.
Pageof 104

Showing results (471-480 of 1,033) with videos related to

Sort By:
Pageof 104
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 4, 1998
IL-3-mediated enhancement of particulate antigen presentation by macrophagesE M Lord, K Y Yeh, J A Moran, et al.
Leukemia Research|January 1, 1990
Phorbol myristate acetate treatment of normal human myeloid blast cells promotes monopoiesis and inhibits granulopoiesisC M Bunce, W N Patton, J D Pound, et al.
Journal of Leukocyte Biology|August 1, 2002
Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokinesGraham M Lord, Giuseppe Matarese, Jane K Howard, et al.
Alimentary Pharmacology & Therapeutics|September 11, 2019
Review article: impact of exercise on physical frailty in patients with chronic liver diseaseFelicity R Williams, Annalisa Berzigotti, Janet M Lord, et al.
Cancer Research|January 15, 1996
2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumorsS M Evans, W T Jenkins, B Joiner, et al.
Haematology and Blood Transfusion|January 1, 1987
Lineage determination during haemopoiesisG Brown, C M Bunce, J M Lord, et al.
The American Journal of Pathology|January 27, 2004
Leptin-deficient mice are protected from accelerated nephrotoxic nephritisRuth M Tarzi, H Terence Cook, Ian Jackson, et al.
Gut|January 26, 2020
Regulatory T-cell therapy in Crohn's disease: challenges and advancesJennie N Clough, Omer S Omer, Scott Tasker, et al.
Hematology (Amsterdam, Netherlands)|June 15, 2007
Circulating T cells in patients with untreated acute myelogenous leukemia are heterogeneous and can be activated through the CD3/TCR complexElisabeth Ersvaer, Peter Hampson, Øystein Wendelbo, et al.
Psychiatric Services (Washington, D.C.)|July 27, 2022
Peer Support Specialist Work and Experiences During the COVID-19 Pandemic: A National Longitudinal StudyWallis E Adams, E Sally Rogers, Emily M Lord, et al.
Pageof 104